Understand your drug candidates’ potential pharmacological profile using a suite of validated in vivo models. Partner with us to select the most appropriate platform, study design, and screening method tailored to each of your individual drug candidates and research question. Each of our models are supported by a range of translational tools including biomarker, in vitro / ex vivo assays, and in silico modelling to optimize lead candidates.
GEMMs – Tumor Homograft (MuPrime™)
Combine the predictive power of GEMM with an improved operational simplicity, consistency, and growth, similar to syngeneic models for your pharmacological research.
Immune Mediated Inflammatory Disease Models
Review our unique collection of highly translatable diabetes, IBD, NASH and rheumatoid arthritis models that allow you to advance your specialist disease therapy